Trial Profile
Efficacy and safety of ipilimumab in patients with pretreated, metastatic, mucosal melanoma
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Expanded access; Therapeutic Use
- Sponsors Bristol-Myers Squibb
- 02 Dec 2015 New trial record